In the newsNews in mediaGenerate your reports faster

In the news | 6th Oct 2021

The Rise of Predictive Modeling and Machine Learning in Biopharma

The biopharma industry may have been slow to embrace digital technologies, but it’s catching up fast. The innovation we’re seeing in predictive modeling and machine learning could truly revolutionize the entire lifecycle of drug discovery and development. Take a look at this piece by Danaher VP Kevin Chance in PharmaTimes, exploring the latest advances and discussing how groundbreaking technologies could transform our industry in the months and years to come: PharmaTimes Magazine

About IDBSContact us

The biopharma industry may have been slow to embrace digital technologies, but it’s catching up fast. The innovation we’re seeing in predictive modeling and machine learning could truly revolutionize the entire lifecycle of drug discovery and development. Take a look at this piece by Danaher VP Kevin Chance in PharmaTimes, exploring the latest advances and discussing how groundbreaking technologies could transform our industry in the months and years to come: PharmaTimes Magazine

i3 2021 On Demand

i3 our premier annual customer event where we bring together science, IT and R&D business leaders to share ideas, create new insights and advance innovation and this year we went virtual. During i3 you will gain insights from your peers…

Read more